ACCENDRA HEALTH INCACHEarnings & Financial Report
NYSE · Consumer Discretionary · Wholesale-Medical, Dental & Hospital Equipment & Supplies
Revenue
$2.6B
Gross Profit
$535.5M
Operating Profit
$9.7M
Net Profit
$-21.9M
Gross Margin
20.5%
Operating Margin
0.4%
Net Margin
-0.8%
YoY Growth
3.6%
EPS
$-0.29
ACCENDRA HEALTH INC Q1 FY2024 Financial Summary
ACCENDRA HEALTH INC reported revenue of $2.6B (up 3.6% YoY) for Q1 FY2024, with a net profit of $-21.9M (up 10.4% YoY) (-0.8% margin). Cost of goods sold was $2.1B, operating expenses totaled $525.8M.
Key Financial Metrics
| Total Revenue | $2.6B |
|---|---|
| Net Profit | $-21.9M |
| Gross Margin | 20.5% |
| Operating Margin | 0.4% |
| Report Period | Q1 FY2024 |
Revenue Breakdown
ACCENDRA HEALTH INC Q1 FY2024 revenue of $2.6B breaks down across 2 segments, led by Products Healthcare Services at $2.0B (75.6% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products Healthcare Services | $2.0B | 75.6% |
| Patient Direct | $637.8M | 24.4% |
ACCENDRA HEALTH INC Annual Revenue by Year
ACCENDRA HEALTH INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.8B).
| Year | Annual Revenue |
|---|---|
| 2025 | $2.8B |
| 2024 | $2.7B |
| 2023 | $2.6B |
| 2022 | $10.0B |
ACCENDRA HEALTH INC Quarterly Revenue & Net Profit History
ACCENDRA HEALTH INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $-1.2B | +2.4% | $-56.3M | 4.5% |
| Q3 FY2025 | $697.3M | +1.5% | $-150.3M | -21.6% |
| Q2 FY2025 | $681.9M | +3.3% | $-869.1M | -127.4% |
| Q1 FY2025 | $2.6B | +0.7% | $-25.0M | -0.9% |
| Q4 FY2024 | $-1.3B | +75.0% | $-296.1M | 23.1% |
| Q3 FY2024 | $686.8M | -73.5% | $-12.8M | -1.9% |
| Q2 FY2024 | $660.4M | -74.2% | $-31.9M | -4.8% |
| Q1 FY2024 | $2.6B | +3.6% | $-21.9M | -0.8% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.61B | $660.4M | $686.8M | $-1.28B | $2.63B | $681.9M | $697.3M | $-1.25B |
| YoY Growth | 3.6% | -74.2% | -73.5% | 75.0% | 0.7% | 3.3% | 1.5% | 2.4% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $5.21B | $5.30B | $5.08B | $4.66B | $4.86B | $4.15B | $4.04B | $2.45B |
| Liabilities | $4.31B | $4.44B | $4.21B | $4.07B | $4.29B | $4.44B | $4.47B | $2.91B |
| Equity | $916.0M | $881.8M | $895.7M | $586.4M | $571.0M | $-281.0M | $-429.5M | $-461.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $-53.0M | $116.1M | $27.3M | $71.0M | $-35.1M | $37.6M | $-172.5M |